Ads
related to: merck & co. pharmaceutical company
Search results
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Zacks via Yahoo Finance· 1 day agoShares of this pharmaceutical company have returned +2.2% over the past month versus the Zacks S&P...
Jim Cramer Advises Investors To Brace For Economic Slowdown, Shares Tips To Maintain Balanced...
Benzinga· 2 days agoJim Cramer, the host of CNBC’s “Mad Money,” has warned investors about the current state of the...
Hearing set to consider penalties for pharmaceutical company over Arkansas law | Northwest Arkansas...
Northwest Arkansas Democrat Gazette· 5 days agoA battle between the Arkansas Insurance Department and pharmaceutical manufacturers is heating up...
Pharma R&D productivity seen improving for the first time in years
Seeking Alpha· 6 days agoDiscover the latest findings on the return on investment from pharmaceutical...
Where America's 34 healthcare billionaires went to college
Becker's ASC Review· 2 days ago"Discover the top 34 healthcare billionaires in the U.S. and where they went to college according to Forbes' annual list of the richest people in the world."
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 4 days agoNew York, USA, May 06, 2024 (GLOBE NEWSWIRE) -- Global Liver Disease Therapeutics Market to Grow Rapidly by 2030, Examines DelveInsight | Key Players in the Market - AbbVie, GSK, F.Hoffmann-La ...
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
Zacks via Yahoo Finance· 3 days agoLooking at individual holdings, West Pharmaceutical Services Inc (WST) accounts for about 1.73% of...
3 Biotech Stocks to Double Your Money in the Next 24 Months
InvestorPlace· 4 days agoThe biotechnology sector is renowned for its potential to deliver groundbreaking medical treatments...
Q1 2024 OPKO Health Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 days agoComplementing these efforts to boost performance, we will continue to improve our diagnostic division to further enhance profitability for AACo health and best position us as an innovative biopharmaceutical ...
Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of...
The Mammoth Times· 7 days agoSentynl, a Zydus Group company, receives worldwide proprietary rights to Zokinvy, adding to portfolio of biopharmaceuticals for rare and ultra-rare diseases
